REVLIMID Drug Use Examination

Trial Profile

REVLIMID Drug Use Examination

Phase of Trial: Phase IV

Latest Information Update: 06 Dec 2017

At a glance

  • Drugs Lenalidomide (Primary) ; Dexamethasone
  • Indications Multiple myeloma
  • Focus Adverse reactions
  • Sponsors Celgene Corporation
  • Most Recent Events

    • 30 Nov 2017 Status changed from active, no longer recruiting to completed.
    • 24 Jan 2017 Status changed from recruiting to active, no longer recruiting.
    • 24 Sep 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top